Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 3Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Gynecologic 5

Conditions

Uterine Cervical Neoplasms 12Papillomavirus Infections 11Neoplasms 10Breast Neoplasms 9Uterine Cervical Dysplasia 7Persistent Infection 5Condylomata Acuminata 5Prostatic Neoplasms 4Melanoma 4Anus Neoplasms 4Vulvar Neoplasms 3Lung Neoplasms 3Herpes Zoster 3Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Vaginal Neoplasms 2Sarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Influenza, Human 2HIV Infections 2Glioma 2Colonic Neoplasms 2Breast Neoplasms, Male 2Wilms Tumor 1Whooping Cough 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Tetanus 1Squamous Cell Carcinoma of Head and Neck 1

Interventions

Vaccines 5hecolin 1Papillomavirus Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Persistent Infection × Vaccines × Clear all
NCT06243666 2025-07-31

Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Xiamen University

Active not recruiting
2,188 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04704908 2023-01-26

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Xiamen University

Unknown
979 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT04969445 2023-01-26

The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Xiamen University

Unknown
647 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05045755 2023-01-26

The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female

Xiamen University

Unknown
1,339 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05426148 2022-06-29

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Xiamen Innovax Biotech Co., Ltd

Phase 4 Completed
540 enrolled
Gynecologic

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡